Literature DB >> 30723661

Lower risk of venous thromboembolism in multiple Asian ethnic groups.

H Nicole Tran1,2, Arthur L Klatsky3,2.   

Abstract

Lower risk of venous thromboembolism in Asians compared to Whites has been suggested. Despite the biological and cultural diversity of Asian Americans, data are sparse for specific ethnic groups. In our prior study of lower Asian American risk, the small number of subjects (337 in all races) precluded accurate study of specific Asian American groups. We present here a new study with 4674 venous thromboembolism subjects diagnosed between 1996 and 2015. Our study population was derived from 61,459 voluntary health examinees in a comprehensive northern California health plan with self-classified ethnicity: 53.0% Whites, 28.4% Blacks, 11.6% ASAMs, 6.8% Others. Of Asian Americans, 44.7% were Chinese, 32.8% Filipinos, 12.9% Japanese, 4.5% South Asians, and 5.0% Other Asians. Chinese, Japanese, Filipinos, and Other Asians each had lower venous thromboembolism risk than both Whites and South Asians, who had risk similar to each other. These data indirectly support a genetic explanation.

Entities:  

Year:  2019        PMID: 30723661      PMCID: PMC6351426          DOI: 10.1016/j.pmedr.2019.01.006

Source DB:  PubMed          Journal:  Prev Med Rep        ISSN: 2211-3355


Background

Lower risk of venous thromboembolism (VTE) in Asians compared to Whites has been suggested (Klatsky et al., 2000; White, 2003; Klatsky and Baer, 2004; Stein and Matta, 2010; Lee et al., 2017; Chen and Liao, 2015). Despite biological and cultural diversity of Asian Americans (ASAM), data are sparse for specific ethnic groups. In our prior study (Klatsky et al., 2000) of lower ASAM risk, the small number of subjects (337 in all races) precluded accurate study of specific ASAM groups. We present here a new study with 4674 VTE subjects.

Methods

Our study population included 61,459 persons in a comprehensive northern California health plan, who underwent voluntary health examinations 1978–85 and remained plan members in 1996, when outpatient diagnoses were computerized. The questionnaire item “What is your race?” ascertained self-classified ethnicity: 53.0% Whites, 28.4% Blacks, 11.6% ASAMs, and 6.8% Other. Of ASAMs, 44.7% were Chinese, 32.8% Filipinos, 12.9% Japanese, 4.5% South Asians (SAs) and 5.0% Other Asians. SAs, mostly Asian Indians, were identified independently before analyses by two investigators using name, birthplace (subject and/or grandparents), gender, and religion. U.S.-born proportions varied markedly: 8% Filipinos, 10% SAs, 11% Other Asians, 43% Chinese, and 79% Japanese. Through 2015, ≥1 VTE diagnoses (ICD-9 codes 451-3 and/or 415.1) were made for 4674 persons during an outpatient visit or hospitalization. With Whites as referent for the entire cohort and SAs as referent for interethnic ASAM comparisons, we studied composite VTE risk by logistic regressions with 5 covariates.

Results

Chinese, Japanese, Filipinos, and Other Asians each had lower VTE risk than both Whites and SAs, who had risk similar to each other (Table 1). Reduced ASAM risk was similar in men, women and subgroups with primary VTE diagnosis of either pulmonary embolism or venous thrombosis (data not shown). Gender, education and smoking were unrelated; increasing age and body mass index were related to progressively increasing risk (data not shown).
Table 1

Adjusted risk of venous thromboembolisms.c

Group (n subjects)n VTEHR (95% CI)p value
Adjusteda risk of venous thromboembolism (VTE) versus Whites
White (32,557)2576Referent
Black (17,442)15541.2 (1.1–1.2)<0.001
All Asian (7254)2680.5 (0.5–0.6)<0.001
 Chinese (3246)1150.5 (0.4–0.6)<0.001
 Japanese (934)350.5 (0.3–0.6)<0.001
 Filipino (2381)920.6 (0.5–0.7)<0.001
 South Asian (328)170.9 (0.5–1.4)0.59
 Other Asian (365)b90.4 (0.2–0.8)0.005
Adjusteda risk of VTE vs South Asians
 South Asian (328)17Referent
 Chinese (3246)1150.6 (0.3–0.9)0.02
 Japanese (934)350.4 (0.2–0.9)0.01
 Filipino (2381)920.5 (0.2–0.9)0.10
 Other Asian (365)b90.4 (0.2–1.0)0.04

Logistic regressions controlled for baseline age, sex, education, BMI, and smoking.

Mostly Korean and Vietnamese.

Studied 1996–2015 in Northern California at Kaiser Permanente.

Adjusted risk of venous thromboembolisms.c Logistic regressions controlled for baseline age, sex, education, BMI, and smoking. Mostly Korean and Vietnamese. Studied 1996–2015 in Northern California at Kaiser Permanente.

Discussion

Concordant lower VTE risk vs. Whites among Chinese, Japanese, Filipinos, and Other Asians suggests presence of acquired or genetic protective traits in East and Southeast Asian ethnic groups (Klatsky and Baer, 2004; Stein and Matta, 2010; Lee et al., 2017; Chen and Liao, 2015). Explanatory acquired traits would need to be present in all groups and persist through many years of acculturation. Known VTE risk traits include factors associated with venous stasis (age, obesity, immobility, trauma, surgery, and travel), and with thrombophilia (estrogen use, pregnancy, cancer, endothelial damage, and certain arteriopathies) (Klatsky and Baer, 2004; Stein and Matta, 2010; Lee et al., 2017; Chen and Liao, 2015). Since we were unable to control most of these or other potential lifestyle factors such as diet or exercise, we cannot rule out a contribution of environmental factors to our findings, which are limited to ASAM in Northern California and may have limited generalizability to other populations. Possible genetic explanations involve genetic polymorphisms leading to dysfunctional anticoagulant systems or decreased hypercoagulable susceptibility. Most prominently this affects the activated protein C anticoagulant system with decreased factor V Leiden (Klatsky and Baer, 2004; Stein and Matta, 2010). Found in ~5% of Caucasians, but rare in East Asians, it may contribute to the ASAM/White disparity (Klatsky and Baer, 2004; Stein and Matta, 2010). Asians may also have lower mean fibrinogen levels and/or lower prevalence of Factor VIIc, Factor VIIIc and prothrombin gene G20210A (Klatsky and Baer, 2004; Stein and Matta, 2010). Although involved in only a minority of VTE cases, clustering and synergy with other coagulation factors may occur. How do SAs fit in this picture? The vast Indian subcontinent is neither culturally nor genetically homogeneous. Genetic studies (Reich et al., 2009; Moorjani et al., 2013) indicate that many northern Indians have gene pools “close to Middle Easterners, Central Asians, and Europeans.” These persons may be geographically Asian but genetically closer to Whites, which would suit our data.

Conclusion

Chinese, Japanese, Filipinos and Other Asian Americans, but not South Asians, had substantially lower VTE risk than Whites. These data indirectly support a genetic explanation.

Support

This work was supported by a Community Budget Grant from The Kaiser Foundation Research Institute to H. Nicole Tran, MD, PhD, PI, in Oakland, CA. Data collection from 1978 to 1985 was supported by a grant from the Alcoholic Beverage Medical Research Foundation to Arthur L. Klatsky, MD, PI, in Oakland, CA. Neither of the authors has any relationship with industry to report.
  8 in total

1.  Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans.

Authors:  A L Klatsky; M A Armstrong; J Poggi
Journal:  Am J Cardiol       Date:  2000-06-01       Impact factor: 2.778

2.  What protects Asians from venous thromboembolism?

Authors:  Arthur L Klatsky; David Baer
Journal:  Am J Med       Date:  2004-04-01       Impact factor: 4.965

3.  Genetic evidence for recent population mixture in India.

Authors:  Priya Moorjani; Kumarasamy Thangaraj; Nick Patterson; Mark Lipson; Po-Ru Loh; Periyasamy Govindaraj; Bonnie Berger; David Reich; Lalji Singh
Journal:  Am J Hum Genet       Date:  2013-08-08       Impact factor: 11.025

Review 4.  Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism.

Authors:  Paul D Stein; Fadi Matta
Journal:  Clin Chest Med       Date:  2010-12       Impact factor: 2.878

5.  Incidence of Venous Thromboembolism in Asian Populations: A Systematic Review.

Authors:  Lai Heng Lee; Alexander Gallus; Ravul Jindal; Chen Wang; Chau-Chung Wu
Journal:  Thromb Haemost       Date:  2017-12-06       Impact factor: 5.249

Review 6.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

7.  Reconstructing Indian population history.

Authors:  David Reich; Kumarasamy Thangaraj; Nick Patterson; Alkes L Price; Lalji Singh
Journal:  Nature       Date:  2009-09-24       Impact factor: 49.962

8.  The Incidence of Deep Vein Thrombosis in Asian Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Chung-Yu Chen; Kuang-Ming Liao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  8 in total
  9 in total

1.  The South Asian Paradox.

Authors:  Arthur L Klatsky; H Nicole Tran
Journal:  Perm J       Date:  2020-04-03

Review 2.  A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.

Authors:  Kai Chin Poh; Victoria Yu Jia Tay; Sarah Huixin Lin; Huei Leng Chee; Suhitharan Thangavelautham
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

3.  Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities.

Authors:  Chuen Wen Tan; Jing Yuan Tan; Wan Hui Wong; May Anne Cheong; Ian Matthias Ng; Edwin Philip Conceicao; Jenny Guek Hong Low; Heng Joo Ng; Lai Heng Lee
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

4.  Editorial: Highlights in Thrombosis: 2021.

Authors:  Colin E Evans
Journal:  Front Cardiovasc Med       Date:  2022-02-24

5.  American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients.

Authors:  Adam Cuker; Eric K Tseng; Robby Nieuwlaat; Pantep Angchaisuksiri; Clifton Blair; Kathryn Dane; Maria T DeSancho; David Diuguid; Daniel O Griffin; Susan R Kahn; Frederikus A Klok; Alfred Ian Lee; Ignacio Neumann; Ashok Pai; Marc Righini; Kristen M Sanfilippo; Deborah M Siegal; Mike Skara; Deirdra R Terrell; Kamshad Touri; Elie A Akl; Reyad Al Jabiri; Yazan Al Jabiri; Angela M Barbara; Antonio Bognanni; Mary Boulos; Romina Brignardello-Petersen; Rana Charide; Luis E Colunga-Lozano; Karin Dearness; Andrea J Darzi; Heba Hussein; Samer G Karam; Razan Mansour; Gian Paolo Morgano; Rami Z Morsi; Giovanna Muti-Schünemann; Menatalla K Nadim; Binu A Philip; Yuan Qiu; Yetiani Roldan Benitez; Adrienne Stevens; Karla Solo; Wojtek Wiercioch; Reem A Mustafa; Holger J Schünemann
Journal:  Blood Adv       Date:  2022-09-13

6.  Rapid progressive vaccine-induced immune thrombotic thrombocytopenia with cerebral venous thrombosis after ChAdOx1 nCoV-19 (AZD1222) vaccination: A case report.

Authors:  Shin-Kuang Jiang; Wei-Liang Chen; Chun Chien; Chi-Syuan Pan; Sheng-Ta Tsai
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

7.  Epidemiology of Cancer-Associated Thrombosis in Asia: A Systematic Review.

Authors:  Lai Heng Lee; Chandramouli Nagarajan; Chuen Wen Tan; Heng Joo Ng
Journal:  Front Cardiovasc Med       Date:  2021-05-21

8.  Experience from a Singapore tertiary hospital with restructuring of a vascular surgery practice in response to national and institutional policies during the COVID-19 pandemic.

Authors:  Jun Jie Ng; Tiffany R X Gan; Jen Yong Niam; Raj K Menon; Pei Ho; Rajesh B Dharmaraj; Julian C L Wong; Andrew M T L Choong
Journal:  J Vasc Surg       Date:  2020-05-23       Impact factor: 4.860

Review 9.  Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Authors:  Toshiaki Iba; Jean Marie Connors; Alex C Spyropoulos; Hideo Wada; Jerrold H Levy
Journal:  Int J Hematol       Date:  2021-01-20       Impact factor: 2.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.